Have a personal or library account? Click to login
Clinical Features and Value of Tracheal Aspirate Metagenomic Next-Generation Sequencing for Severe Pneumonia in Children in Pediatric Intensive Care Unit Cover

Clinical Features and Value of Tracheal Aspirate Metagenomic Next-Generation Sequencing for Severe Pneumonia in Children in Pediatric Intensive Care Unit

Open Access
|Jun 2025

Figures & Tables

Fig. 1.

Flow diagram of patient inclusion and exclusion.
Flow diagram of patient inclusion and exclusion.

Fig. 2.

The pathogen detected results of mNGS and CMT.
A) The types of infection identified in the children with severe pneumonia. The solid pie chart represents the proportion of single and mixed infections, and the other two hollow pie charts represent the specific pathogen types of single and mixed infections.
B) The coincidence between mNGS and CMT for pathogen identification.
The pathogen detected results of mNGS and CMT. A) The types of infection identified in the children with severe pneumonia. The solid pie chart represents the proportion of single and mixed infections, and the other two hollow pie charts represent the specific pathogen types of single and mixed infections. B) The coincidence between mNGS and CMT for pathogen identification.

Fig. 3.

The distribution of the identified pathogen spectrum.
A) The distribution of pathogens detected by mNGS and CMT.
B) The distribution of pathogens for children in the < 12 months group and the 12~144 months group.
The distribution of the identified pathogen spectrum. A) The distribution of pathogens detected by mNGS and CMT. B) The distribution of pathogens for children in the < 12 months group and the 12~144 months group.

Fig. 4.

Analysis of microbiome alpha and beta diversity between patients < 12 months and 12~144 months.
A) Alpha diversity differences of microbiota communities at the species level between groups. Each point represents one sample from each group. B) PCoA plot is based on Bray–Curtis’s distance between the children in groups. The x-axis is for grouping information, the y-axis is for distance information, the R-value is between (–1, 1) and there are significant differences between groups when the R-value is greater than zero and the P value is less than 0.05.
Analysis of microbiome alpha and beta diversity between patients < 12 months and 12~144 months. A) Alpha diversity differences of microbiota communities at the species level between groups. Each point represents one sample from each group. B) PCoA plot is based on Bray–Curtis’s distance between the children in groups. The x-axis is for grouping information, the y-axis is for distance information, the R-value is between (–1, 1) and there are significant differences between groups when the R-value is greater than zero and the P value is less than 0.05.

Fig. 5.

The top 20 microorganisms and their correlation with patient clinical data.
A) Top 20 most abundant species and their relative abundance. B) Differences between age groups for the top 20 most abundant microbes. * p-adjust < 0.05; ** p-adjust < 0.01; *** padjust < 0.001. Metastats analysis, p-value was adjusted using the Benjamini and Hochberg method. C) LEfSe analysis of respiratory microbiome between patients < 12 months and 12~144 months. Bar chart showing the log-transformed LDA scores of pathogen species identified by LEfSe analysis (the log-transformed LDA score of 4 as the threshold).
The top 20 microorganisms and their correlation with patient clinical data. A) Top 20 most abundant species and their relative abundance. B) Differences between age groups for the top 20 most abundant microbes. * p-adjust < 0.05; ** p-adjust < 0.01; *** padjust < 0.001. Metastats analysis, p-value was adjusted using the Benjamini and Hochberg method. C) LEfSe analysis of respiratory microbiome between patients < 12 months and 12~144 months. Bar chart showing the log-transformed LDA scores of pathogen species identified by LEfSe analysis (the log-transformed LDA score of 4 as the threshold).

Fig. 6.

Spearman correlations between the top 20 most abundant species and clinical data. * 0.01 < p < 0.05; ** 0.001 < p ≤ 0.01; *** p ≤ 0.001.
Spearman correlations between the top 20 most abundant species and clinical data. * 0.01 < p < 0.05; ** 0.001 < p ≤ 0.01; *** p ≤ 0.001.

Demographic and clinical characteristics of patients_

CharacteristicsSevere pneumonia (n = 55)Children less than 12 months (n = 33)Children aged 12~144 months (n = 22)p-valuea
Age, month (M, IQR)5.97 (3.28–30.50)3.70 (2.80–4.63)40.50 (24.75–51.75)< 0.0001
< 1233///
12–14422///
Gender, male, n (%)24 (43.64%)18 (54.55%)6 (27.27%)0.0457
Symptoms, n (%)
Fever24 (43.64%)9 (27.27%)15 (68.18%)0.0027
Cough41 (74.55%)26 (78.79%)15 (68.18%)0.3764
Abnormal breathing51 (92.73%)33 (100%)18 (72%)0.0012
Unconsciousness6 (10.91%)3 (9.09%)3 (13.64%)0.5963
Apathetic43 (78.18%)23 (69.70%)20 (90.91%)0.0620
Fidgety10 (18.18%)2 (6.06%)8 (36.36%)0.0043
Laboratory examination (mean ± SD)
Pulse (times per minute)106.9 ± 28.95172.88 ± 22.49143 ± 28.69<0.0001
Respiratory rate (times per minute)42.31 ± 11.3944.55 ± 9.9538.96 ± 12.770.0742
WBC10.42 ± 4.7911.03 ± 4.529.49 ± 5.140.2465
Hb105.8 ± 18.72104.82 ± 14.19107.27 ± 24.300.6382
PLT368.13 ± 183.67441.64 ± 187.03257.86 ± 110.540.0001
NEUT%12.38 ± 23.539.60 ± 17.4116.56 ± 30.530.2866
LY%12.36 ± 23.3817.66 ± 28.214.42 ± 9.150.0386
NEUT5.02 ± 3.803.82 ± 2.496.80 ± 4.710.0035
HCT31.38 ± 7.9131.38 ± 6.7931.38 ± 9.520.9990
CRP21.06 ± 43.047.35 ± 19.8041.63 ± 58.540.0029
PCT2.61 ± 6.850.91 ± 2.845.09 ± 9.780.0260
BUN4.93 ± 4.614.67 ± 2.955.33 ± 6.440.6157
Arterial blood pH7.38 ± 0.087.37 ± 0.087.40 ± 0.080.2710
PaO258.29 ± 17.3757.67 ± 14.0359.23 ± 21.770.7474
PaCO243.78 ± 12.7047.33 ± 11.4438.45 ± 12.880.0097
HCO326.32 ± 8.2626.93 ± 5.1425.40 ± 11.550.5058
PaO2/FiO2213.13 ± 64.00221.33 ± 48.89200.82 ± 81.410.2478
Premature, n7 (12.73%)6 (18.18%)1 (4.55%)0.1371
Post operation, n3 (5.45%)1 (3.03%)2 (9.09%)0.3322
Intubation, n30 (54.55%)19 (57.58%)11 (50%)0.5804
Mechanical ventilation, n30 (54.55%)19 (57.58%)11 (50%)0.5804
SOFA score3.58 ± 2.033.48 ± 1.683.73 ± 2.510.6691
APACHE II score13.45 ± 4.6913.58 ± 3.9513.27 ± 5.720.8167
LOHS (mean ± SD), day16.49 ± 8.8317.39 ± 9.7215.14 ± 7.300.3579
ICU (mean ± SD), day15.24 ± 8.8716.76 ± 9.7512.96 ± 6.970.1203
Outcomes, n
Cured53 (96.36%)32 (96.97%)21 (95.45%)0.7687
Died2 (3.64%)1 (3.03%)1 (4.55%)0.7687
DOI: https://doi.org/10.33073/pjm-2025-016 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 192 - 205
Submitted on: Jan 20, 2025
|
Accepted on: Apr 25, 2025
|
Published on: Jun 18, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 XINYAN YU, JIUCHAO LIANG, RUI YANG, WEI GAI, YAFENG ZHENG, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.